Transactions 2023

Private Banking|Professional Solutions|Investment Management|Investment Banking|About us

Transactions 2023

zealand

Sole Financial Adviser

Venture debt financing

Sole Bookrunner

€51.8 million

Financial Adviser

U.S. Private Placement

wdp

Joint Global Coordinator and Joint Bookrunner

Accelerated Bookbuild Offering

Joint Global Coordinator & Joint Bookrunner

Accelerated Bookbuild Offering

galapagos

Financial Adviser

Sale of Jyseleca business to Alfasigma

Joint Global Coordinator & Joint Bookrunner

SEK 59.3 million

Directed Share Issue

Joint Global Coordinator & Joint Lead Bookrunner

NOK 505 million

Accelerated Bookbuild Offering

Sole Financial Adviser

synact pharma

Sole Financial Adviser

SEK 120 million

Structured Equity with Warrants

Financial Adviser

Acquisition of Novec GmbH

Joint Bookrunner

Accelerated Bookbuild Offering

DHG

Sole Financial Adviser

Proposed investment in Stedin Groep

merus

USD 173 million

Capital Increase

argenx

USD 1.3 billion

Capital Increase

nsi

Sole Financial Adviser

Secured Term Loan Extension

Sole Financial Adviser

vicore pharma

Joint Bookrunner

SEK 500 million

Capital increase

Financial Adviser

USD 182 million

Secondary sell-down

Joint Global Coordinator & Joint Bookrunner

€25.0 million

Accelerated Bookbuild Offering

Sole Financial Adviser

terrapay

Financial Adviser

>USD 100 million

Series B funding round

sequana medical

Joint Global Coordinator & Joint Bookrunner

€ 15.8 million

Accelerated Bookbuild Offering

zealand

DKK 1.5 billion

Accelerated Bookbuild Offering

Sole Financial Adviser

Series B funding round

Financial Advisor, Capital Markets Advisor & Placement Agent

PIPE USD 91 million

curevac

USD 250 million

US Public Offering

Sole Financial Adviser

circa € 500 million

Structured Equity and Senior Debt Financing